ArticleFrontiers in pharmacology2026
Locomotor and discriminative stimulus effects of N-cyclohexyl butylone and N-cyclohexyl methylone.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: N-Cyclohexyl butylone and N-cyclohexyl methylone are cathinones found on the street that produce morbidity and mortality, but are not yet legally controlled, and there has been little or no pharmacological testing of these compounds. Both compounds have a large moiety on the N-position that may alter their pharmacological effects. Methods: Locomotor stimulant effects of N-cyclohexyl butylone and N-cyclohexyl methylone were tested in male Swiss-Webster mice. N-Cyclohexyl butylone and N-cyclohexyl methylone were tested in male Sprague-Dawley rats trained to discriminate methamphetamine (1 mg/kg), cocaine (10 mg/kg) or 3,4-methylenedioxymethamphetamine (MDMA, 1.5 mg/kg) from saline. Results: Both N-cyclohexyl butylone (ED Conclusion: N-cyclohexyl butylone may produce psychostimulant-like effects adequate to motivate illicit use, whereas the weak psychostimulant-like effects of N-cyclohexyl methylone may suggest a reduced liability for illicit use, but the compound may be more dangerous due to its convulsant effects. The N-cyclohexyl moiety may have contributed to the reduced efficacy of N-cyclohexyl methylone, while the longer alpha-side chain of N-cyclohexyl butylone may have countered the effect of the large N-position moiety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.